TheraCann International Benchmark Corp.

No. 279: A new flu review, taking the fight to tuberculosis and why your fish might really like a cold beer

Welcome to Wednesday: And over the hump we go, dear readers, with another week of Long Island innovation and socioeconomic progress in full swing. It was 179 years ago today, on Feb. 7, 1839, when U.S. Senator Henry Clay of Kentucky – warned that a speech would offend abolitionists and pro-slavery factions alike, and could cost him the presidential election – told Congress, “I had rather be right than be president.” The nose knows: Walt…


Smoking-hot biotech sparks key cannabis contract

By GREGORY ZELLER // It’s another new high for Applied DNA Sciences. Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the Stony Brook-based biotech lit up again Thursday, announcing a new contract to develop molecular tracking systems for a worldwide network of legal cannabis supplies. The two-year, $1 million development and marketing agreement with Canadian supplier TheraCann International Benchmark Corp. – which provides turn-key pharmaceutical solutions…